secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001730463-26-000049
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus Therapeutics dismisses EY UK and appoints EY US as independent auditor
------------------------------------------------------------------------------

- Audit committee dismissed EY UK on April 14, 2026; no disagreements or reportable events in prior two fiscal years.
- Audit committee appointed EY US as new independent auditor for FY 2026, effective immediately.
- EY UK's audit reports for 2024 and 2025 were unqualified; prior material weakness in internal controls disclosed in Q1 2024 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000173046326000049/0001730463-26-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000173046326000049/autl-20260414.htm
  HTML page:      https://secwatch.observer/filing/0001730463-26-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer